• Citer

Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934).

par Piccart-Gebhart, Martine ;Rozencweig, Marcel ;Dodion, Pierre ;Cumps, E;Crespeigne, Nadine;Makaroff, O;Atassi, Ghanem ;Kisner, D;Kenis, Y
Référence European journal of cancer & clinical oncology, 17, 12, page (1263-1266)
Publication Publié, 1981-12

Article révisé par les pairs

• Détails

Titre:	Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934).
Auteur:	Piccart-Gebhart, Martine; Rozencweig, Marcel; Dodion, Pierre; Cumps, E; Crespeigne, Nadine; Makaroff, O; Atassi, Ghanem; Kisner, D; Kenis, Y
Informations sur la publication:	European journal of cancer & clinical oncology, 17, 12, page (1263-1266)
Statut de publication:	Publié, 1981-12
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Alopecia -- chemically induced
	Antineoplastic Agents -- administration & dosage
	Antineoplastic Agents -- toxicity
	Dose-Response Relationship, Drug
	Drug Evaluation
	Female
	Humans
	Infusions, Parenteral
	Leukopenia -- chemically induced
	Male
	Middle Aged
	Nausea -- chemically induced
	Neoplasms -- drug therapy
	Thrombophlebitis -- chemically induced
	Triazines -- administration & dosage
	Triazines -- toxicity
	Vomiting -- chemically induced
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	Research Support, U.S. Gov't, P.H.S.
Langue:	Anglais
Identificateurs:	urn:issn:0277-5379
	info:pmid/7200026